Schedule 13D ownership disclosure

SUNESIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 867328601

Event date: 2015-12-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.5200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-15-410880
Form type
SC 13D/A
Filer
Bay City Capital Fund V, L.P.
CIK
CIK 1401826
Filed
Dec 22, 2015
Reporting period
Dec 21, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub